Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway
Saved in:
| Main Authors: | Ferhat Dindaş, Hüseyin Güngör, Mehmet Ekici, Pınar Akokay, Füsun Erhan, Mustafa Doğduş, Mehmet Birhan Yılmaz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2021-11-01
|
| Series: | Anatolian Journal of Cardiology |
| Online Access: | https://anatoljcardiol.com/jvi.aspx?un=AJC-28709&volume=25&issue=11 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiotensin Receptor–Neprilysin Inhibition (Sacubitril/Valsartan) Reduces Structural Arterial Stiffness in Middle‐Aged Mice
by: Isabel N. Schellinger, et al.
Published: (2024-02-01) -
Experience of sacubitril/valsartan therapy in hypertension
by: E. V. Oshchepkova
Published: (2023-09-01) -
Potential of valsartan+sacubitril therapy in hypertensive heart disease
by: A. G. Ovchinnikov, et al.
Published: (2021-08-01) -
The use of sacubitril/valsartan in different forms of heart failure
by: Mohammad Abumayyaleh, et al.
Published: (2025-06-01) -
Effects of sacubitril-valsartan in patients undergoing maintenance dialysis
by: Ying Ding, et al.
Published: (2023-12-01)